Cepi And Samsung Biologics Collaborate To Strengthen Outbreak-Ready Vaccine Production And Global Access
Feb 3 (Reuters) - Samsung Biologics Co Ltd 207940.KS:
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.